학술논문

Methylation of the chromatin modifier KMT2D by SMYD2 contributes to therapeutic response in hormone-dependent breast cancer
Document Type
Article
Source
In: Cell Reports. (Cell Reports, 28 May 2024, 43(5))
Subject
Language
English
ISSN
22111247